EMA ready to roll on Ebola
This article was originally published in Scrip
Executive Summary
As soon as data are available for Ebola drugs and vaccines, the European Medicines Agency (EMA) on 22 October said it was keen to take a look – declaring it has put in place regulatory processes aimed at allowing "the best experts from across Europe" to accelerate the assessment processes.